Health ❯ Pharmaceuticals

Biotechnology

Clinical Trials Drug Development mRNA Technology Vaccine Development Regulatory Approvals Biotech Companies Covid-19 Vaccines Nanomedicine Nanobodies Pharma Companies Viral Therapies RNA Therapeutics Collaborations AI in Medicine Investment in Healthcare Cancer Treatment Bioactive Compounds Women’s Health Innovations Antibody Research Life Sciences International Collaboration Weight Loss Antisense Oligonucleotides Cancer Treatments Insulin Production Patent Law

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

The lead asset SYH2082 is progressing into Phase 1 following the signing.

Lead-Plaintiff Deadline Nears in MoonLake Securities Suits After SLK Trial Miss

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in Securities Class Action

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

Rani Therapeutics and Chugai Sign Oral Biologics Collaboration Worth Up to $1.085 Billion

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

Resalis’ miR-22 Antisense Shows Durable Fat Loss in Animals as Phase 1 Trial Continues

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

Albumin-PLGA Nanoparticles Enable Ultrahigh Drug Loading and Six-Month Stability